T47D - Cell Line (ID:50541)
| HMS LINCS ID: | 50541 |
| Name: | T47D |
| Alternative Names: | T-47D |
| LINCS ID: | LCL-1486 |
| Alternative ID: | CLO_0009251 |
| Parent Cell Line: | |
| Reference Source: | ATCC HTB-133 |
| Organism: | Homo sapiens |
| Organ: | breast |
| Tissue: | |
| Cell Type: | |
| Details of Cell Type: | |
| Donor Sex: | female |
| Donor Age: | |
| Donor Ethnicity: | |
| Donor Health Status: | |
| Disease: | DOID:3459, breast carcinoma |
| Details of Disease: | |
| Production Details: | |
| Genetic Modification(s): | none |
| Known Mutations: | |
| Citation Information for Mutations: | COSS905945 |
| Verification Reference Profile: | |
| Growth Properties: | adherent |
| Recommended Culture Conditions: | From MGH/CMT as specified by cell provider: RPMI 1640 or DMEM + 2mM Glutamine + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm2 using 0.25% trypsin or trypsin or trypsin/EDTA; 5% CO2; 37C. |
| Relevant Citations: | |
| Usage Note: | |
| Comments: | |
| Date Publicly Available: | 2012-07-31 |
| Most Recent Update: | 2016-07-12 |
Batch Information for HMSL50541-2:
| HMS LINCS Batch ID: | 50541-2 |
| Provider: | Mario Niepel (Harvard Medical School) |
| Provider Catalog ID: | |
| Provider Batch ID: | |
| Source Information: | Obtained by Mario Niepel (Harvard Medical School) from ATCC as part of the ICBP43 Collection in July, 2010, and distributed to Mohammad Fallahi-Sichani in December of 2012. |
| Date Received: | 2012-12 |
| HMS QC Outcome: | |
| Transient Modification(s): | |
| Comments: | |
| Date Publicly Available: | 2016-06-06 |
| Most Recent Update: | 2016-07-12 |